Pages:

• [draft] Media – articles and videos
• About
  • Contact
  • Core facilities
    • Clinical Record Interactive Search
    • Oxford Centre for Human Brain Activity
  • Management and partners
    • Profile: Bill Wells – Oxford Health BRC Finance Manager
    • Profile: John Geddes – Oxford Health BRC Director
    • Profile: Marco Pontecorvi – Oxford Health BRC Manager
    • Profile: Nick Broughton – Oxford Health BRC Chair, Steering Committee
  • Stay in touch
  • Work with us
• About Patient and Public Involvement
  • Patient and Public Involvement Strategy
  • Resources for researchers
  • Resources for the public
  • Shape our research
    • Join our PPI contributor group
    • Opportunity to join our Patients and Research Strategy Group
    • Patients & Research Strategy Group Terms of Reference
  • Take part in our research
  • Young people’s involvement
    • Ground rules for digital meetings
    • Meaningful and inclusive digital involvement
    • NEUROSEC Young People’s Advisory Group Terms of Reference
    • Research on sensitive topics – briefing for researchers
• Accessibility
  • Accessibility statement for Oxford Health Biomedical Research Centre
• Cookies and Privacy Policy
• Disclaimer
• Home
• NIHR Oxford cognitive health Clinical Research Facility
• NIHR Oxford Cognitive Health Clinical Research Facility
  • CRF publications
  • Examples of Clinical Research Facility activity
  • Get involved
  • Our staff
  • Taking part in research at the CRF
  • What can the Clinical Research Facility offer?
• Our Work
  • CASE STUDY 6 – A multidisciplinary trial reveals the potential of breakthrough research to better diagnose and treat psychosis patients
  • Treatment Resistant Depression Clinic
    • Treatment Resistant Depression Clinic – FAQs
  • Welcome to Oxford Dementia and Ageing Research (OxDARE)
    • Our research
      • To understand how the brain and cognitive skills are affected by ageing and disease
      • To improve assessments & early diagnoses
      • To identify and deliver effective interventions for modifying the risk of cognitive decline
      • To deliver breadth and depth of data to researchers
      • Involving the Public
    • For researchers
    • For the public
      • Friends of OxDARE registration
    • News and events
  • Welcome to the Brain Health Centre
    • The Brain Health Assessment
      • Information for Patients
      • Information for Researchers
  • Welcome to the Oxford Precision Psychiatry Lab (OxPPL)
    • Benzodiazepines and Z-drugs (zopiclone and zolpidem)
    • Digital technologies and telepsychiatry
    • Domestic violence and abuse
    • International collaborators
    • International projects
    • Lithium treatment
    • Long-acting injectable (LAI) antipsychotics
    • Media – articles and videos
    • OxPPL Events
    • OxPPL Team
    • Patient Involvement and Ethics
    • Pregnancy and the perinatal period
    • Publications
    • Suicide and self-harm
    • Systematic reviews and meta-analysis
    • Vaccine prioritisation and mental health
    • Clozapine treatment
    • COVID-19 & clinical management of mental health issues
    • Inpatient wards
    • End of life care
• Psychiatry department seminars
• Research Themes
  • Adult Mental Health: Innovation in Diagnosis and Treatment
    • Recent Publications – Adult Mental Health
  • Clinical Research Infrastructure and Experimental Medicine
    • Recent publications – Clinical Research Infrastructure and Experimental Medicine
  • Informatics and Digital Health
    • Recent publications – Informatics and Digital Health
  • Neuroimaging and Cognitive Neuroscience
    • Recent publications – Neuroimaging and Cognitive Neuroscience
  • Older Adults and Dementia
    • Recent publications – Older Adults and Dementia
  • Patient and Public Involvement (PPI)
  • Precision Psychological Therapies
    • Recent publications – Precision Psychological Therapies
  • Theme Leads
    • Profile: Andrea Cipriani
    • Profile: Anke Ehlers
    • Profile: Catherine Harmer
    • Profile: Clare Mackay
    • Profile: Elizabeth Tunbridge
    • Profile: Ilina Singh
    • Profile: Kia Nobre
    • Profile: Paul Harrison
  • Training
• Sitemap
• Alzheimer’s Research UK Thames Valley Network Members
• CASE STUDY 1 – The Brain Health Centre – bringing research and clinical services together for better patient outcomes
• CASE STUDY 2 – Accelerating the development of more effective antidepressants to improve patient outcomes
• CASE STUDY 3 – A new approach to measuring memory in people at high risk of Alzheimers
• CASE STUDY 4 – How, why, and when cardiovascular risk factors impact brain health
• CASE STUDY 5 – A breakthrough approach to quickly and accurately matching individual patients to the right antidepressants

Categories:

• Blog
• News

Authors:

• Catherine Kernot (47)
• Claire Murray (11)
• oxfordhealth (32)
• wpengine (1)

Monthly:

• January 2021
• December 2020
• November 2020
• October 2020
• September 2020
• July 2020
• June 2020
• May 2020
• April 2020
• March 2020
• February 2020
• January 2020
• December 2019
• October 2019
• September 2019
• June 2019
• May 2019
• April 2019
• March 2019
• February 2019
• January 2019
• September 2018
• August 2018
• June 2018
• May 2018
• April 2018
• February 2018
• December 2017
• November 2017
• October 2017
• September 2017
• August 2017
• June 2017
• May 2017
• April 2017
• March 2017

Recent Posts:

• Join our patient, carer and public involvement groups
• Almost a third of UK population are very unsure or strongly hesitant about COVID-19 vaccination
• Opt-out approach to research benefits patients and staff
• Oxford Brain Health Centre celebrates high levels of research participation and positive feedback from patients
• 20% of COVID-19 patients receive a psychiatric diagnosis within 90 days
• Virtual Work Experience – capturing ‘digital voices’ in research
• Involving young people to guide research into peer interactions and mental health using VR tools in schools
• New UKRI/NIHR funding for tackling Covid’s impact on mental health
• Research involvement opportunity for parents
• Innovative new Brain Health Centre – first of its kind in UK
• COVID-19 and mental health research at Oxford Health BRC
• New Programme Helps Frontline Healthcare Workers at Risk from PTSD and Depression
• PPI in the time of COVID-19
• New national study into the long-term health impacts of COVID-19
• Study to explore mental health benefits of online cultural experiences
• OxCADAT guidance for remote delivery of psychological therapies
• Talk on evidence-based guidance for digital technologies and telepsychiatry during COVID19
• Supporting mental health and resilience in first responders – operational training is most effective
• Excessive mistrust linked to conspiracy beliefs reduces the following of government coronavirus guidance
• Patient and Public Involvement: the journey so far
• New guidance and resources to help patients cope with trauma after intensive care
• Effects of Social Isolation and Lockdown on Adolescents in Oxfordshire
• Let them know you care – social disconnection worsens mental health after a loss
• Genetic risk factors for mental illness affect how children’s brains are wired up
• BRC Senior Research Fellows appointed
• New research seeks to tackle impact of COVID-19 on children and young people’s mental health
• COVID-19 Research impact and mental health resources
• Would you like to help shape a research project?
• Lack of comparative data on new therapeutic agents poses a challenge to health care systems
• Oxford Brain Health Clinical Trials Unit – Open Day
• Shining a light on mental health on International Women’s Day
• Professor Andrea Cipriani appointed as Oxford cognitive health CRF Director
• New photography exhibition showcases groundbreaking research
• NIHR Oxford Health Biomedical Research Centre senior fellows competition
• Oxford Health appoints new Chief Executive
• ‘If you are curious about a career in experimental medicine then OxCEMM is for you’
• Oxford Academic Paper Writing Retreat for Nurses – March 2020
• Link between calcium abnormality and bipolar disorder
• Antipsychotic drugs ranked according to metabolic side effects for the first time
• Getting your research funded: working with patients and public
• Severe reactions to grief can be predicted and treated in the first months following a bereavement
• Large scale analysis of antipsychotics could improve outcomes for schizophrenia patients
• Help us improve how research interacts with electronic health records
• Preventing dementia – join our focus group for a new research project
• Oxford Short Course in Experimental Medicine for Mental Health – OxCEMM
• New study shows close monitoring is essential to ensure safety of ketamine for depression
• Academic Writing Retreat for Nurses – September 2019
• gameChange clinical trial – how virtual reality could transform psychological therapy in the NHS
• Analysis of antidepressant dosage highlights need for new clinical guidelines
• New spinout from Oxford – Cristal Health
• Join our patient advisory group for a new research study!
• Mental Health and Dementia Research Open Day
• SUSANA Survey to Increase Understanding of the Side Effects of Antidepressants in Adults
• Oxford Health BRC PhD Scholar at the University of Oxford
• Mental Health & Dementia Research Open Day
• Patient and carer involvement in early psychosis research
• Cannabis use in teens raises risk of depression in young adults
• Can you help us improve True Colours?
• The UK’s leading mental health experts unite to solve treatment challenges
• Continued professional development meeting on how to manage mood disorders
• Oxford Short Course in Experimental Medicine for Mental Health
• Help us develop Oxford’s new Brain Health Centre
• Oxford Dementia Research Day 2018
• Help us develop an app for antipsychotics
• Animated film for patient and public involvement in research
• Use your lived experience to shape our work
• Body-worn sensors to assess walking may help detect Alzheimer’s disease
• Open Day: find out about mental health research in Oxford
• Antidepressants are more effective than placebo at treating acute depression in adults
• Free talk: New developments in Parkinson’s and Alzheimer’s research
• Virtual benefits for the real world
• Major NIHR award to develop VR treatment in the NHS for mental health disorders
• Cycling Down Dementia: Simon Lovestone bikes to receive knighthood
• Triple win for Oxford at the RCPsych Awards 2017
• Dolphin brains show signs of Alzheimer’s Disease
• Profile: Theme lead Clare Mackay
• Preventing dementia: how hard can it be?
• Treating insomnia may reduce mental health problems
• NY Times: ‘England’s Mental Health Experiment: No-Cost Therapy’
• BRC part-funded researcher wins Oxford University public engagement award
• How close are we to finding a cure for Alzheimer’s?
• Oxford Health tops table for recruitment to research
• Simon Lovestone knighted in Queen’s Birthday honours
• Oxford Dementia Research Day
• New Oxford Health Associate R&D Director
• ‘Getting the right level of oversight’
• The future in mind
• Talk: Fixing the Brain Before it’s Broken
• NeuroNight at the Museum
• Finding mental health and dementia treatments of the future
• New funding for virtual reality treatments for mental health problems